CHRS
Coherus BioSciences Inc
Price:  
1.22 
USD
Volume:  
1,866,563.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS WACC - Weighted Average Cost of Capital

The WACC of Coherus BioSciences Inc (CHRS) is 8.6%.

The Cost of Equity of Coherus BioSciences Inc (CHRS) is 12.80%.
The Cost of Debt of Coherus BioSciences Inc (CHRS) is 7.35%.

Range Selected
Cost of equity 10.90% - 14.70% 12.80%
Tax rate 0.10% - 1.10% 0.60%
Cost of debt 7.00% - 7.70% 7.35%
WACC 7.9% - 9.2% 8.6%
WACC

CHRS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.54 1.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.90% 14.70%
Tax rate 0.10% 1.10%
Debt/Equity ratio 3.38 3.38
Cost of debt 7.00% 7.70%
After-tax WACC 7.9% 9.2%
Selected WACC 8.6%